O'Shea PJ - Search Results

1

Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.

Gilmour PS, O'Shea PJ, Fagura M, Pilling JE, Sanganee H, Wada H, Courtney PF, Kavanagh S, Hall PA, Escott KJ. Gilmour PS, et al. Among authors: o shea pj. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):399-407. doi: 10.1016/j.taap.2013.07.001. Epub 2013 Jul 18. Toxicol Appl Pharmacol. 2013. PMID: 23872097 Free article.

2

Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.

Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W, Croucher PI, Bellantuono I. Gambardella A, et al. Among authors: o shea pj. J Bone Miner Res. 2011 Apr;26(4):811-21. doi: 10.1002/jbmr.266. J Bone Miner Res. 2011. PMID: 20939016 Free article.

3

Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor.

Cook DA, Fellgett SW, Pownall ME, O'Shea PJ, Genever PG. Cook DA, et al. Among authors: o shea pj. Stem Cell Res. 2014 Mar;12(2):415-27. doi: 10.1016/j.scr.2013.10.002. Epub 2013 Oct 16. Stem Cell Res. 2014. PMID: 24382458 Free article.

4

Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.

O'Shea PJ, Kim DW, Logan JG, Davis S, Walker RL, Meltzer PS, Cheng SY, Williams GR. O'Shea PJ, et al. J Biol Chem. 2012 May 18;287(21):17812-17822. doi: 10.1074/jbc.M111.311464. Epub 2012 Mar 22. J Biol Chem. 2012. PMID: 22442145 Free PMC article.

5

Insight into the physiological actions of thyroid hormone receptors from genetically modified mice.

O'Shea PJ, Williams GR. O'Shea PJ, et al. J Endocrinol. 2002 Dec;175(3):553-70. doi: 10.1677/joe.0.1750553. J Endocrinol. 2002. PMID: 12475367 Review.

6

A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone.

O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR. O'Shea PJ, et al. Mol Endocrinol. 2003 Jul;17(7):1410-24. doi: 10.1210/me.2002-0296. Epub 2003 Apr 3. Mol Endocrinol. 2003. PMID: 12677005

7

Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta.

O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR. O'Shea PJ, et al. Mol Endocrinol. 2005 Dec;19(12):3045-59. doi: 10.1210/me.2005-0224. Epub 2005 Jul 28. Mol Endocrinol. 2005. PMID: 16051666

8

Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter.

O'Shea PJ, Guigon CJ, Williams GR, Cheng SY. O'Shea PJ, et al. Endocrinology. 2007 Dec;148(12):5966-76. doi: 10.1210/en.2007-0114. Epub 2007 Aug 30. Endocrinology. 2007. PMID: 17761769

9

Analysis of thyroid hormone responsive gene expression in osteoblastic cells.

Harvey CB, Stevens DA, Williams AJ, Jackson DJ, O'Shea P, Williams GR. Harvey CB, et al. Mol Cell Endocrinol. 2003 Dec 31;213(1):87-97. doi: 10.1016/j.mce.2003.10.037. Mol Cell Endocrinol. 2003. PMID: 15062577

10

Thyroid hormone activates fibroblast growth factor receptor-1 in bone.

Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ, Brady G, Samarut J, Chassande O, Williams GR. Stevens DA, et al. Mol Endocrinol. 2003 Sep;17(9):1751-66. doi: 10.1210/me.2003-0137. Epub 2003 Jun 12. Mol Endocrinol. 2003. PMID: 12805413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters